{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:00:53Z","timestamp":1791856853896,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H02492"],"award-info":[{"award-number":["15H02492"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H01015"],"award-info":[{"award-number":["19H01015"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22J14778"],"award-info":[{"award-number":["22J14778"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04313"],"award-info":[{"award-number":["17H04313"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H00548"],"award-info":[{"award-number":["20H00548"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22dm0207073"],"award-info":[{"award-number":["JP22dm0207073"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"MEXT | Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJMS2024"],"award-info":[{"award-number":["JPMJMS2024"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016846","name":"Shimadzu Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016846","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sadako O. Hirai Ban Award for Young Researchers"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyloid-\u03b2 (A\u03b2) deposition in the brain parenchyma is one of the pathological hallmarks of Alzheimer disease (AD). We have previously identified amyloid precursor protein (APP)669-711 (a.k.a. A\u03b2(-3)-40) in human plasma using immunoprecipitation combined with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (IP-MALDI-MS). Furthermore, we found that the level of a composite biomarker, i.e., a combination of APP669-711\/A\u03b21-42 ratio and A\u03b21-40\/A\u03b21-42 ratio in human plasma, correlates with the amyloid PET status of AD patients. However, the production mechanism of APP669-711 has remained unclear. Using in vitro and in vivo assays, we identified A Disintegrin and Metalloproteinase with a Thrombospondin type 1 motif, type 4 (ADAMTS4) as a responsible enzyme for APP669-711 production. ADAMTS4 cleaves APP directly to generate the C-terminal stub c102, which is subsequently proteolyzed by \u03b3-secretase to release APP669-711. Genetic knockout of <jats:italic>ADAMTS4<\/jats:italic> reduced the production of endogenous APP669-711 by 30% to 40% in cultured cells as well as mouse plasma, irrespectively of A\u03b2 levels. Finally, we found that the endogenous murine APP669-711\/A\u03b21-42 ratio was increased in aged AD model mice, which shows A\u03b2 deposition as observed in human patients. These data suggest that ADAMTS4 is involved in the production of APP669-711, and a plasma biomarker determined by IP-MALDI-MS can be used to estimate the level of A\u03b2 deposition in the brain of mouse models.<\/jats:p>","DOI":"10.1038\/s41380-023-01946-y","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:15:39Z","timestamp":1675217739000},"page":"1802-1812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["ADAMTS4 is involved in the production of the Alzheimer disease amyloid biomarker APP669-711"],"prefix":"10.1038","volume":"28","author":[{"given":"Masaya","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8258-2678","authenticated-orcid":false,"given":"Miyabishara","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yota","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honoka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Korenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadanori","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-997X","authenticated-orcid":false,"given":"Gabriel","family":"Opoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-5943","authenticated-orcid":false,"given":"Taisuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"1946_CR1","doi-asserted-by":"crossref","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Prim. 2021;7:33.","DOI":"10.1038\/s41572-021-00269-y"},{"key":"1946_CR2","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1002\/jcb.26129","volume":"118","author":"K Kikuchi","year":"2017","unstructured":"Kikuchi K, Kidana K, Tatebe T, Tomita T. Dysregulated metabolism of the amyloid-\u03b2 protein and therapeutic approaches in Alzheimer disease. J Cell Biochem. 2017;118:4183\u201390.","journal-title":"J Cell Biochem"},{"key":"1946_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell."},{"key":"1946_CR4","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science."},{"key":"1946_CR5","first-page":"398","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: appropriate use recommendations. J Prev Alzheimer\u2019s Dis. 2021;8:398\u2013410.","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"1946_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43). Neuron. 1994;13:45\u201353.","journal-title":"Neuron."},{"key":"1946_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ana.410370305","volume":"37","author":"T Iwatsubo","year":"1995","unstructured":"Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y. Amyloid \u03b2 protein (A\u03b2) deposition: A\u03b242(43) precedes A\u03b240 in down syndrome. Ann Neurol. 1995;37:294\u20139.","journal-title":"Ann Neurol"},{"key":"1946_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido TC, Iwatsubo T, Mann DMA, Shimada H, Ihara Y, Kawashima S. Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron. 1995;14:457\u201366.","journal-title":"Neuron."},{"key":"1946_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.8191290","volume":"264","author":"N Suzuki","year":"1994","unstructured":"Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L, Eckman C, et al. An increased percentage of long amyloid \u03b2 protein secreted by familial amyloid \u03b2 protein precursor (\u03b2APP717) mutants. Science. 1994;264:1336\u201340.","journal-title":"Science"},{"key":"1946_CR10","doi-asserted-by":"publisher","first-page":"10272","DOI":"10.1021\/bi00032a022","volume":"34","author":"A Asami-Odaka","year":"1995","unstructured":"Asami-Odaka A, Ishibashi Y, Kikuchi T, Kitada C, Suzuki N. Long amyloid \u03b2-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry. 1995;34:10272\u20138.","journal-title":"Biochemistry."},{"key":"1946_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2183\/pjab.90.353","volume":"90","author":"N Kaneko","year":"2014","unstructured":"Kaneko N, Nakamura A, Washimi Y, Kato T, Sakurai T, Arahata Y, et al. Novel plasma biomarker surrogating cerebral amyloid deposition. Proc Jpn Acad Ser B Phys Biol Sci. 2014;90:353\u201364.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1946_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249\u201354.","journal-title":"Nature."},{"key":"1946_CR13","doi-asserted-by":"crossref","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, Allu\u00e9 JA, Sarasa L, Eichenlaub U, et al. Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease. JAMA Neurol. 2021;78:1375\u201382.","DOI":"10.1001\/jamaneurol.2021.3180"},{"key":"1946_CR14","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/hmg\/ddab146","volume":"30","author":"M Araki","year":"2021","unstructured":"Araki M, Ito K, Takatori S, Ito G, Tomita T. BORCS6 is involved in the enlargement of lung lamellar bodies in Lrrk2 knockout mice. Hum Mol Genet. 2021;30:1618\u201331.","journal-title":"Hum Mol Genet"},{"key":"1946_CR15","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.1096\/fj.201902966RR","volume":"34","author":"YW Chiu","year":"2020","unstructured":"Chiu YW, Hori Y, Ebinuma I, Sato H, Hara N, Ikeuchi T, et al. Identification of calcium and integrin-binding protein 1 as a novel regulator of production of amyloid \u03b2 peptide using CRISPR\/Cas9-based screening system. FASEB J. 2020;34:7661\u201374.","journal-title":"FASEB J"},{"key":"1946_CR16","doi-asserted-by":"crossref","unstructured":"Gopalappa R, Suresh B, Ramakrishna S, Kim HH. Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption. Nucleic Acids Res. 2018;46:e71.","DOI":"10.1093\/nar\/gky222"},{"key":"1946_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1177\/002215540305101011","volume":"51","author":"T Isaka","year":"2003","unstructured":"Isaka T, Nestor AL, Takada T, Allison DC. Chromosomal variations within aneuploid cancer lines. J Histochem Cytochem. 2003;51:1343\u201353.","journal-title":"J Histochem Cytochem"},{"key":"1946_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature. 1992;360:672\u20134.","journal-title":"Nature."},{"key":"1946_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1126\/science.8424174","volume":"259","author":"X-D Cai","year":"1993","unstructured":"Cai X-D, Golde TE, Younkin SG. Release of excess amyloid \u03b2 protein from a mutant amyloid \u03b2 protein precursor. Science. 1993;259:514\u20136.","journal-title":"Science."},{"key":"1946_CR20","doi-asserted-by":"publisher","first-page":"31894","DOI":"10.1074\/jbc.271.50.31894","volume":"271","author":"R Wang","year":"1996","unstructured":"Wang R, Sweeney D, Gandy SE, Sisodia SS. The profile of soluble amyloid \u03b2 protein in cultured cell media. J Biol Chem. 1996;271:31894\u2013902.","journal-title":"J Biol Chem"},{"key":"1946_CR21","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1523\/JNEUROSCI.2595-20.2021","volume":"41","author":"K Kikuchi","year":"2021","unstructured":"Kikuchi K, Tatebe T, Sudo Y, Yokoyama M, Kidana K, Chiu YW, et al. GPR120 signaling controls amyloid-\u03b2 degrading activity of matrix metalloproteinases. J Neurosci. 2021;41:6173\u201385.","journal-title":"J Neurosci"},{"key":"1946_CR22","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1523\/JNEUROSCI.3135-07.2007","volume":"27","author":"HS Hoe","year":"2007","unstructured":"Hoe HS, Cooper MJ, Burns MP, Lewis PA, Van Der Brug M, Chakraborty G, et al. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J Neurosci. 2007;27:10895\u2013905.","journal-title":"J Neurosci"},{"key":"1946_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-018-1929-5","volume":"137","author":"S Walter","year":"2019","unstructured":"Walter S, Jumpertz T, H\u00fcttenrauch M, Ogorek I, Gerber H, Storck SE, et al. The metalloprotease ADAMTS4 generates N-truncated A\u03b24\u2013x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer\u2019s disease. Acta Neuropathol. 2019;137:239\u201357.","journal-title":"Acta Neuropathol"},{"key":"1946_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-10-133","volume":"10","author":"S Lemarchant","year":"2013","unstructured":"Lemarchant S, Pruvost M, Montaner J, Emery E, Vivien D, Kanninen K, et al. ADAMTS proteoglycanases in the physiological and pathological central nervous system. J Neuroinflammation. 2013;10:1\u20138.","journal-title":"J Neuroinflammation"},{"key":"1946_CR25","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1002\/jcb.23298","volume":"112","author":"P Verma","year":"2011","unstructured":"Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 2011;112:3507\u201314.","journal-title":"J Cell Biochem"},{"key":"1946_CR26","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.1074\/jbc.C000848200","volume":"276","author":"M Kashiwagi","year":"2001","unstructured":"Kashiwagi M, Tortorella M, Nagase H, Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem. 2001;276:12501\u20134.","journal-title":"J Biol Chem"},{"key":"1946_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0014-5793(01)02323-7","volume":"494","author":"G Hashimoto","year":"2001","unstructured":"Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 2001;494:192\u20135.","journal-title":"FEBS Lett"},{"key":"1946_CR28","doi-asserted-by":"publisher","first-page":"11101","DOI":"10.1074\/jbc.M611588200","volume":"282","author":"R Hills","year":"2007","unstructured":"Hills R, Mazzarella R, Fok K, Liu M, Nemirovskiy O, Leone J, et al. Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate. J Biol Chem. 2007;282:11101\u20139.","journal-title":"J Biol Chem"},{"key":"1946_CR29","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1523\/JNEUROSCI.6467-10.2011","volume":"31","author":"N Takasugi","year":"2011","unstructured":"Takasugi N, Sasaki T, Suzuki K, Osawa S, Isshiki H, Hori Y, et al. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J Neurosci. 2011;31:6850\u20137.","journal-title":"J Neurosci"},{"key":"1946_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/693746","volume":"2014","author":"K Demircan","year":"2014","unstructured":"Demircan K, Topcu V, Takigawa T, Akyol S, Yonezawa T, Ozturk G, et al. ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury. Biomed Res Int. 2014;2014:1\u20138.","journal-title":"Biomed Res Int"},{"key":"1946_CR31","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1002\/chem.201600892","volume":"22","author":"I Beyer","year":"2016","unstructured":"Beyer I, Rezaei-Ghaleh N, Klafki HW, Jahn O, Hau\u00dfmann U, Wiltfang J, et al. Solid-phase synthesis and characterization of N-terminally elongated A\u03b2\u22123\u2013x-peptides. Chem A Eur J 2016;22:8685\u201393.","journal-title":"Chem A Eur J"},{"key":"1946_CR32","first-page":"1","volume":"00","author":"HW Klafki","year":"2022","unstructured":"Klafki HW, Wirths O, Mollenhauer B, Liepold T, Rieper P, Esselmann H, et al. Detection and quantification of A\u03b2\u22123\u201340 (APP669-711) in cerebrospinal fluid. J Neurochem. 2022;00:1\u201312.","journal-title":"J Neurochem"},{"key":"1946_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"1946_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001;17:157\u201365.","journal-title":"Biomol Eng"},{"key":"1946_CR35","doi-asserted-by":"crossref","unstructured":"Armbrust F, Bickenbach K, Marengo L, Pietrzik C, Becker-Pauly C. The Swedish dilemma\u2014the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative \u03b2-secretases. Biochim Biophys Acta Mol Cell Res. 2022;1869:119164.","DOI":"10.1016\/j.bbamcr.2021.119164"},{"key":"1946_CR36","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1126\/science.1067568","volume":"295","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. Brain to plasma amyloid-\u03b2 efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease. Science. 2002;295:2264\u20137.","journal-title":"Science"},{"key":"1946_CR37","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Ram Kumar S, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer\u2019s amyloid-\u03b21-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489\u201399.","journal-title":"J Clin Invest"},{"key":"1946_CR38","doi-asserted-by":"publisher","first-page":"9632","DOI":"10.1523\/JNEUROSCI.2236-04.2004","volume":"24","author":"T Shiiki","year":"2004","unstructured":"Shiiki T, Ohtsuki S, Kurihara A, Naganuma H, Nishimura K, Tachikawa M, et al. Brain insulin impairs amyloid-\u03b2(1-40) clearance from the brain. J Neurosci. 2004;24:9632\u20137.","journal-title":"J Neurosci"},{"key":"1946_CR39","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1523\/JNEUROSCI.2021-09.2009","volume":"29","author":"K Yamada","year":"2009","unstructured":"Yamada K, Yabuki C, Seubert P, Schenk D, Hori Y, Ohtsuki S, et al. A\u03b2 immunotherapy: Intracerebral sequestration of A\u03b2 by an anti-A\u03b2 monoclonal antibody 266 with high affinity to soluble A\u03b2. J Neurosci. 2009;29:11393\u20138.","journal-title":"J Neurosci"},{"key":"1946_CR40","doi-asserted-by":"crossref","unstructured":"Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, et al. GWAS on family history of Alzheimer\u2019s disease. Transl Psychiatry. 2018;8:99.","DOI":"10.1038\/s41398-018-0150-6"},{"key":"1946_CR41","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1946_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, et al. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol. 2010;120:185\u201393.","journal-title":"Acta Neuropathol"},{"key":"1946_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biopha.2009.09.012","volume":"64","author":"Y Zha","year":"2010","unstructured":"Zha Y, Chen Y, Xu F, Li T, Zhao C, Cui L. ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes. Biomed Pharmacother. 2010;64:160\u20134.","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01946-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01946-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01946-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T05:03:55Z","timestamp":1684904635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-01946-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-01946-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"13 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NK, HN, AK, SS, SI, and KT are full-time employees of Shimadzu Corporation, Japan. Other authors have no other conflicts of interest in association with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}